Cost Effectiveness of Paliperidone Palmitate Versus Risperidone Long-Acting Injectable, Quetiapine and Olanzapine for the Treatment of Patients with Schizophrenia in Colombia
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.2088
https://www.valueinhealthjournal.com/article/S1098-3015(13)04000-X/fulltext
Title :
Cost Effectiveness of Paliperidone Palmitate Versus Risperidone Long-Acting Injectable, Quetiapine and Olanzapine for the Treatment of Patients with Schizophrenia in Colombia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)04000-X&doi=10.1016/j.jval.2013.08.2088
First page :
A695
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1911